Abstract
Purpose
Between combined and staged operations of carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG) for patients with concurrent coronary and carotid disease, each treatment strategy has its own advantages and disadvantages. We attempted to compare early surgical results between the two operations.
Methods
We retrospectively reviewed medical records of 71 patients who underwent either combined CEA & CABG (n=37) or staged CABG & CEA (n=34) in a single institute between January 2001 and March 2010. After comparing patients' demographics and preoperative neurologic and cardiac status, we compared early (<1 month) postoperative cardiac or neurologic complications and surgical mortality between the 2 groups.
Results
There was no significant difference in patients' demographics and indications for operation the between 2 groups. There were 2 (5.4%) cases of postoperative stroke in combined groups and 1 (2.9%) in staged group. However, there was no myocardial infarction or death. In staged operation group, during the interval time between the two operations, 5 cases (14.7%) of stroke developed, of which, all patients recovered without any sequelae by anticoagulation.
Conclusion
After experiencing low postoperative cardiac or neurologic morbidity or mortality after combined CABG and CEA, we conclude that combined CABG and CEA was a safe and feasible treatment option for patients with neurologic symptoms and in stable cardiac status. In the staged operation group of patients, we observed development of neurologic events during the interval period between CABG and CEA. To attain optimal treatment strategy in asymptomatic patients, further prospective study would be required.
Go to : 

References
1. Faggioli GL, Curl GR, Ricotta JJ. The role of carotid screening before coronary artery bypass. J Vasc Surg. 1990; 12:724–9. discussion. 729–31.


2. Jausseran JM, Bergeron P, Reggi M, Chiche G, Serra-Rosset G, Courbier R. Single staged carotid and coronary arteries surgery. Indications and results. J Cardiovasc Surg (Torino). 1989; 30:407–13.
3. Ricotta JJ, Wall LP, Blackstone E. The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study. J Vasc Surg. 2005; 41:397–401. discussion. 401–2.


4. Perler BA. Managing patients with clinically significant cardiac and carotid artery occlusive disease. Arch Surg. 2009; 144:998–9.


5. Li Y, Walicki D, Mathiesen C, Jenny D, Li Q, Isayev Y, et al. Strokes after cardiac surgery and relationship to carotid stenosis. Arch Neurol. 2009; 66:1091–6.


6. Akins CW, Hilgenberg AD, Vlahakes GJ, Madsen JC, MacGillivray TE, LaMuraglia GM, et al. Late results of combined carotid and coronary surgery using actual versus actua-rial methodology. Ann Thorac Surg. 2005; 80:2091–7.


7. Naylor AR, Cuffe RL, Rothwell PM, Bell PR. A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. Eur J Vasc Endovasc Surg. 2003; 25:380–9.


8. Naylor AR, Mehta Z, Rothwell PM, Bell PR. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg. 2002; 23:283–94.
9. Naylor AR, Mehta Z, Rothwell PM. A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass. Eur J Vasc Endovasc Surg. 2009; 37:379–87.


10. Bae JS, Lee S, Yoon SS, Choi SH, Park JK, Kim SN, et al. Combined carotid endarteretomy and coronary artery bypass graft: two cases report. J Korean Soc Vasc Surg. 2002; 18:149–55.
11. Lim HI, Lee KB, Sung KI, Lee YT, Kim DI. Surgical approach of concomitant coronary and carotid artery disease. J Korean Surg Soc. 2006; 71:197–201.
12. Brown KR, Kresowik TF, Chin MH, Kresowik RA, Grund SL, Hendel ME. Multistate population-based outcomes of combined carotid endarterectomy and coronary artery bypass. J Vasc Surg. 2003; 37:32–9.


13. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators. N Engl J Med. 1996; 335:1857–63.
14. Das SK, Brow TD, Pepper J. Continuing controversy in the management of concomitant coronary and carotid disease: an overview. Int J Cardiol. 2000; 74:47–65.


15. Naylor AR. The importance of initiating "best medical therapy" and intervening as soon as possible in patients with symptomatic carotid artery disease: time for a radical rethink of practice. J Cardiovasc Surg (Torino). 2009; 50:773–82.
16. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004; 44:e213–310.
17. Ghosh J, Murray D, Khwaja N, Murphy MO, Walker MG. The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing coronary artery bypass surgery. Eur J Vasc Endovasc Surg. 2005; 29:88–90.


18. Naylor R, Cuffe RL, Rothwell PM, Loftus IM, Bell PR. A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: influence of surgical and patient variables. Eur J Vasc Endovasc Surg. 2003; 26:230–41.


19. Mackey WC, Khabbaz K, Bojar R, O'Donnell TF Jr. Simultaneous carotid endarterectomy and coronary bypass: perioperative risk and long-term survival. J Vasc Surg. 1996; 24:58–64.


20. Mickleborough LL, Walker PM, Takagi Y, Ohashi M, Ivanov J, Tamariz M. Risk factors for stroke in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996; 112:1250–8. discussion. 8–9.


21. Naylor AR. Managing patients with symptomatic coronary and carotid artery disease. Perspect Vasc Surg Endovasc Ther. 2010; 22:70–6.
Go to : 

Table 1.
Patients demographics
Combined (n=37) | Staged (n=34) | P | |
---|---|---|---|
Male | 31 (84%) | 29 (85%) | 0.861 |
Age (mean, year) | 68.7±6.4 | 66.6±8.2 | 0.231 |
Smoking history | 12 (32%) | 22 (65%) | 0.007 |
Hypertension | 29 (78%) | 21 (62%) | 0.125 |
Diabetes mellitus | 22 (60%) | 15 (44%) | 0.196 |
Atrial fibrillation | 1 (3%) | 2 (6%) | 0.604 |
CRF* | 3 (8%) | 2 (6%) | 1.000 |
COPD† | 3 (8%) | 4 (12%) | 0.699 |
Table 2.
Preoperative cardiac profiles and coronary artery bypass grafting (CABG) procedures
Combined (n=37) | Staged (n=34) | P | |
---|---|---|---|
LV* ejection fraction | 57±13.3% | 56.3±9.9% | 0.335 |
Clinical feature of CAD† | 0.879 | ||
Stable angina | 22 (61%) | 22 (67%) | |
Unstable angina ‡ | 10 (28%) | 7 (21%) | |
Acute MI‡ | 4 (11%) | 4 (12%) | |
No. of diseased coronary arteries | |||
1 or 2 vessels | 8 (22%) | 3 (9%) | 0.137 |
3 vessels | 29 (78%) | 31 (91%) | |
CABG procedures | |||
Cardiac arrest | 3 (8%) | 4 (13%) | 0.696 |
OPCABG§ | 33 (89%) | 28 (88%) | 1.000 |
Aorta clamping | 9 (24%) | 4 (13%) | 0.210 |
Table 3.
Clinical features of carotid stenosis (CS)
Combined (n=37) | Staged (n=34) | P | |
---|---|---|---|
Ipsilateral CS*>70% | 35 (94.6%) | 30 (88.2%) | 0.417 |
Contralateral CS>70% | 15 (40.5%) | 8 (23.5%) | 0.126 |
Presence of plaque ulcer | 6 (16.2%) | 2 (5.9%) | 0.264 |
Any previous neurologic symptom | 12 (32.4%) | 5 (14.7%) | 0.082 |
Neurologic symptom within 6 months | 4 (10.8%) | 1 (2.9%) | 0.359 |
No neurologic symptom | 33 (89.2%) | 33 (97.1%) | |
Ipsilateral CS>70% with contralateral carotid occlusion | 9 (27.3%) | 1 (3.0%) | 0.006 |
Bilateral CS>70% | 15 (45.5%) | 7 (21.2%) | 0.037 |
Table 4.
Postoperative morbidity and mortality
Combined (n=37) | Staged (n=34) | P | |
---|---|---|---|
Duration of follow-up (mean, mo) | 53.3±27.3 | 64.1±32.9 | 0.134 |
Operative morbidity | |||
General | |||
Postoperative bleeding | 0 | 3 (8.8%) | |
CEA site | 0 | 2 (5.9%) | |
CABG site | 0 | 1 (2.9%) | |
Neurologic | 2 (5.4%) | 6 (17.6%) | 0.141 |
Stroke* ≤1 month | 2 (5.4%) | 1 (2.9%) | 1.000 |
Stroke* during the waiting time for CEA† after CABG‡ | NA | 5 (14.7%) | |
Cardiac | |||
Acute myocardial infarction | 0 | 0 | |
Arrhythmia | 0 | 0 | |
Operative mortality | 0 | 0 |